جستجوی استاد راهنمای دانشگاهی

Jean-Philippe MARTINET is a Lecturer in Parasitology at the School of Pharmacy , University of Reims Champagne-Ardenne. He specializes in medical and veterinary entomology, focusing on mosquito-borne zoonotic viruses (West Nile, Usutu) and entomopathogenic nematodes of the Mermithidae family. His work spans vector ecology, transmission dynamics, and climate change impacts on disease vectors. Pharmacist (Faculty of Pharmacy, Reims) Master's in Natural Environment Engineering: Wildlife and Environment PhD in Medical and Veterinary Entomology (defended 2021) Research Interests Vectorial transmission of arboviruses Mosquito surveillance and ecological modeling Temperature-dependent virus transmission Mermithid nematodes as biological control agents Recent Article Trends emphasize experimental studies on mosquito vector competence, climate change effects on Aedes species, and taxonomic advancements in disease vectors. His collaborations include the Pasteur Institute of New Caledonia and EA7510 ESCAPE. Laboratory Affiliations : Dengue and Arbovirus Research and Expertise Unit (UREDA) at Pasteur Institute of New Caledonia; EA7510 ESCAPE research unit in Reims.

• Medical Entomology
• Parasitology
• Virology
• +۴ مورد دیگر

Lucy Glover is a Researcher and Group Leader of the Trypanosome Molecular Biology laboratory at the Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France. She joined the institute in March 2016 as a G5 group leader, focusing on the molecular mechanisms of antigenic variation and DNA repair in Trypanosoma brucei , the causative agent of Human African Trypanosomiasis. Her research integrates molecular, biochemical, and high-throughput approaches to study DNA recombination and immune evasion. Institut Pasteur, Paris (2016–Present) PhD, London School of Hygiene and Tropical Medicine Her research interests center on antigenic variation , DNA repair , and homologous recombination in trypanosomes. She investigates how DNA double-strand breaks influence variant surface glycoprotein (VSG) switching, a critical process for parasite survival in the host. Her lab uses advanced techniques such as RIT-seq, phosphoproteomics, and CRISPR-based tools to dissect these mechanisms at the molecular level. The recent publications of Lucy Glover span molecular parasitology, DNA damage response, and diagnostic development. Key themes include the role of the MRN complex in DNA repair, phosphoproteomic profiling of DNA damage responses, and the design of CRISPR-based diagnostics for HAT. Her work reveals how chromosomal context influences repair pathways and antigenic variation, contributing to a deeper understanding of parasite biology. While no formal scientific awards are listed in the provided text, her contributions are evident through high-impact publications and leadership in collaborative research projects. Lucy Glover advises several PhD and postdoctoral researchers, including Emilia MacLaughlin, Nuria Sima Teruel, and Alix Thivolle. Her lab is supported by institutional initiatives such as LabEx IBEID and transversal drug discovery programs. She collaborates with teams working on host-pathogen interactions, genomics, and infectious disease epidemiology. Her laboratory is part of the Department of Parasites and Insect Vectors and participates in departmental retreats and seminars. The team includes post-docs, research engineers, and administrative staff, reflecting a collaborative and interdisciplinary research environment focused on combating neglected tropical diseases.

• Molecular Parasitology
• DNA Repair
• Antigenic Variation
• +۷ مورد دیگر

Nolwenn Dheilly is a researcher at the Pasteur Institute in Paris, France, contributing to studies on emerging infectious diseases, particularly in the areas of virology, parasitology, and microbiome science. She is actively involved in pathogen discovery and molecular characterization of viruses and parasites, with a focus on zoonotic agents and host-pathogen interactions. Her research interests span Virology , Parasitology , Microbiome , Emerging Infectious Diseases , Zoonoses , Metagenomics , Molecular Virology , and Host-Pathogen Interactions . Her work integrates molecular biology, genomics, and ecological perspectives to understand how microbial communities influence parasitic life cycles and disease transmission. The recent publications highlight a strong trend in viral discovery and classification, including work on Jingchuvirales, circoviruses, and flaviviruses like West Nile and tick-borne encephalitis virus. Her research also explores the virome of parasites and the role of symbiotic microbes in helminth evolution. These studies are critical for advancing diagnostics, understanding disease emergence, and informing public and veterinary health strategies. Scientific Awards: No awards listed in the provided text. Advising and Grants: No formal students or grants are mentioned in the available information. However, her collaborative work across multiple institutions and projects, including Labex IBEID and ANR PREZODE AMAZED, suggests active participation in funded research initiatives and interdisciplinary teams. Labs and Teams: She is part of a research group at the Pasteur Institute led by Marc Eloit, focusing on pathogen discovery and metagenomics. Her collaborations extend to teams working on veterinary virology, arboviruses, and parasitic microbiomes, indicating integration within a broad network of infectious disease research.

• Virology
• Parasitology
• Microbiome
• +۵ مورد دیگر

R.-A. Lavergne serves as an Assistant Professor and Hospital Practitioner at the University of Nantes, specializing in medical mycology with a focus on antifungal resistance mechanisms and environmental drivers of resistance. Their work bridges clinical practice and environmental microbiology through the One Health framework, investigating azole resistance in Aspergillus species and diagnostic innovations for fungal pathogens. Educational background includes a PhD on Aspergillus fumigatus resistance mechanisms defended at the University of Nantes in July 2018. Advanced training encompasses molecular diagnostics, antifungal susceptibility testing, and environmental sampling methodologies. Research centers on azole resistance evolution in Aspergillus , particularly TR-mutation pathways (TR34/L98H, TR46/Y121F/T289A), and agricultural fungicide impacts on clinical resistance. Key projects examine sterol biosynthesis alterations under drug pressure, environmental reservoirs in crop fields, and novel antifungal compounds like CIN-102. Diagnostic work includes Mucorales DNA detection in serum and MALDI-TOF optimization for cryptic Candida species. Recent publications reveal three dominant research axes: (1) Environmental origins of resistance (Colombian crop studies); (2) Molecular mechanisms of TR-mutation-mediated resistance; (3) Diagnostic innovations for mucormycosis and rare fungal pathogens. This integrated approach spans genomic, biochemical, and epidemiological methodologies. Active involvement in national research initiatives includes ANR TEILEISH, ANR AspergillusOne-Health, ANR Chair INSERM COMBINE, ANR OTARI, ANR AspergIs, ANR FungiSol, and ANR INTERLUDE. Collaborative networks span French cystic fibrosis centers, transplant units, and international agricultural health projects. As part of the Department of Medical Mycology and Parasitology, Dr. Lavergne contributes to clinical diagnostics for immunocompromised patients while leading environmental resistance surveillance. The research group maintains active collaborations with Prof. Le Pape's team on resistance mechanisms and Prof. Morio's diagnostics unit.

• Antifungal Resistance
• Medical Mycology
• Aspergillus fumigatus
• +۳ مورد دیگر

Thomas Cokelaer is a researcher at the Institut Pasteur, affiliated with the Bioinformatics and Biostatistics HUB and based at the Platform Biomics. Since October 2018, he has led the SALSA (dry-lab) group, focusing on bioinformatics software development and data analysis. His interdisciplinary background spans astronomy, plant modeling, systems biology, and drug discovery. Institution: Institut Pasteur Unit: Bioinformatics and Biostatistics HUB Platform: Platform Biomics Group: SALSA (dry-lab group) leader His research interests center on bioinformatics, next-generation sequencing (NGS) analysis, machine learning, data visualization, and reproducible research. He develops and maintains several widely used open-source tools including Sequana (NGS pipelines), BioServices (biological web services), Bioconvert (format conversion), Sequanix (GUI for Snakemake), and GDSCTools (pharmacogenomics). He is deeply committed to promoting reproducibility in computational research through initiatives like reprohackathons. The recent publications reflect a strong trend in computational biology, with a focus on developing bioinformatics methodologies, improving data analysis workflows, and applying these tools to diverse biological problems such as fungal pathogenesis, cancer pharmacogenomics, mitochondrial metabolism, and viral evolution. The work spans genomics, transcriptomics, systems biology, and software engineering. He has contributed to numerous scientific software projects as Principal Investigator, including Sequana, Bioconvert, GDSCTools, DREAMTools, and Sequanix. He has also taught courses in scientific programming with Python and reproducible data analysis at the Institut Pasteur. His collaborative network includes researchers from EMBL-EBI, Sanger Institute, INRIA, and international partners within the Pasteur Network. The SALSA group hosts master’s students and visiting researchers annually.

• Bioinformatics
• Data Analysis
• Machine Learning
• +۱۲ مورد دیگر

Romain Libbrecht is a CNRS Research Fellow at the University of Tours, France, affiliated with the Research Institute on Insect Biology (IRBI) under the UFR of Sciences and Techniques. Previously, he held positions as an Assistant Professor at the University of Mainz and conducted postdoctoral research internationally. His research focuses on understanding phenotypic plasticity and division of labor in social insects, particularly ants, integrating evolutionary biology, behavioral ecology, molecular biology, and epigenetics. Education highlights include a PhD from the University of Lausanne (2012), a Master’s from the University of Rennes (2007), and research internships at the University of Reading (2005-2006). His work explores how environmental and social factors influence ant behavior, physiology, and gene expression through multi-disciplinary approaches. Research interests emphasize the molecular mechanisms underlying caste differentiation, task specialization, and social organization. Key findings include the role of transcriptional activity in response to queen loss, the impact of worker diversity on colony productivity, and sensory-driven division of labor via odorant receptors. His articles consistently investigate insect social systems, with recent work focusing on invasive ant species and the interplay between parasite load and host physiology. No notable awards are listed, but his contributions to ant genomics and epigenetics have advanced understanding of social evolution. Lab affiliations include the IRBI, where he collaborates on projects bridging ecology and molecular biology. No specific grants or advising roles are detailed, but his transcontinental academic journey reflects a commitment to global scientific collaboration.

• Social Insect Biology
• Phenotypic Plasticity
• Behavioral Ecology
• +۳ مورد دیگر

Anas Cherqui is an Assistant Professor at the University of Picardie Jules Verne, where he serves in the Department of Life and Earth Sciences within the Faculty of Sciences. With his HDR (Habilitation à Diriger des Recherches) qualification, he has been actively contributing to entomological research and teaching since at least 2006. His academic career includes significant administrative roles such as Co-Director of the Life and Earth Sciences Degree (2010-2018) and Co-manager of the Agroecology Course since 2018. Dr. Cherqui's research focuses on insect physiology, particularly plant-aphid interactions, protein biochemistry, and host-parasitoid relationships. His work explores how insects interact with their host plants, the molecular mechanisms of plant defense responses, and the identification of proteins with potential agricultural applications. His research has evolved to include investigating parasitoid wasp venoms for potential therapeutic applications, particularly in cancer treatment. His publication record shows consistent productivity with research spanning electropenetrography (EPG) studies of aphid feeding behavior, molecular analysis of salivary proteins, plant defense mechanisms, and the biochemical characterization of insect immune responses. Recent work has focused on pea aphid resistance mechanisms, plant manipulation strategies by aphids, and the potential medical applications of hymenopteran venoms. Dr. Cherqui has secured multiple competitive research grants including ANR projects, regional council funding, and SATT-NORD initiatives totaling over €200,000 in project leadership. His research has practical applications in developing alternative pest control strategies and understanding plant-insect coevolution. As an educator, he teaches entomology, insect immunity, and innovative agrosystems at the Master's level, and fundamental immunology, cell biology, and insect biology at the Bachelor's level. He has co-supervised multiple PhD students working on topics related to aphid-plant interactions and parasitoid virulence mechanisms.

• Insect Physiology
• Plant-Aphid Interaction
• Protein Biochemistry
• +۴ مورد دیگر

Caroline Charlier-Woerther is a distinguished Associate Professor of Medicine specializing in Infectious Diseases and Tropical Medicine at Paris Descartes University (Sorbonne Paris Cité) and a Senior Scientist at the French National Reference Center and WHO Collaborating Center on Listeria at the Institut Pasteur. She serves within the Biology of Infection Unit (Inserm U1117) and the Division of Infectious Diseases and Tropical Medicine at the Necker-Pasteur Center for Infectious Diseases, Assistance Publique–Hôpitaux de Paris. Her career bridges clinical practice, research, and academic teaching with a primary focus on listeriosis and other infectious diseases. Dr. Charlier-Woerther's research interests center on Listeria monocytogenes pathogenesis, particularly maternal-fetal transmission, neonatal listeriosis, and host genetic factors influencing susceptibility to infection. Her work examines how Listeria crosses critical biological barriers (intestinal, blood-brain, and placental) and the resulting clinical outcomes. She has made significant contributions to understanding neonatal listeriosis presentation and long-term neurological consequences, as well as antimicrobial resistance patterns in Listeria strains. Her extensive publication record in high-impact journals demonstrates her leadership in the field of listeriosis research. The recent publications reveal a consistent focus on clinical epidemiology of Listeria infections, neonatal outcomes, and antimicrobial resistance patterns. Her research combines clinical observation with molecular analysis to understand virulence heterogeneity and host adaptation of Listeria monocytogenes. Gold Medal of the Residency Program (Médaille d'Or du Concours de Médecine de l'Internat) 2005 Award CNRS/APHP for PhD program 2006 Young scientist award of the French Medical Mycology Society 2008 ASM ICAAC Infectious Diseases Fellows Grant at the 50th ICAAC in Boston 2010 Dr. Charlier-Woerther serves as Principal Investigator for two major research projects: LISTERIAGEN (ANR), which aims to identify host genetic factors associated with susceptibility to listeriosis, and MONALISA (Multicenter Observational National Analysis on Listeriosis and Listeria). She has received multiple research grants supporting her work on listeriosis and related infections. As an educator, she has taught infectious diseases since 2004 at Paris Descartes University Medical School and implemented an international infectious diseases course for students from multiple European institutions since 2014. She is actively involved in multiple professional organizations including the Faculty of 1000 Infectious Diseases, the Collège des Universitaires des Maladies Infectieuses et Tropicales, and the Editorial board of La Presse Médicale. Her work at the Necker-Pasteur Center for Infectious Diseases positions her at the forefront of clinical infectious disease management and research in France.

• Listeriosis
• Infectious Diseases
• Tropical Medicine
• +۴ مورد دیگر

Mathilde Gendrin is a Junior Group Leader at Institut Pasteur de la Guyane since 2017. Her research focuses on the critical role of mosquito microbiota in regulating vectorial capacity for malaria and other diseases, bridging laboratory and field-based approaches. 2019: HDR from Université de Paris 2010: PhD from Université Pierre et Marie Curie 2005: MSc from Université Pierre et Marie Curie 2004: MSc from ENS Lyon Dr. Gendrin’s research explores: Host-pathogen-microbiota tripartite interactions Sex-specific nutritional requirements in mosquitoes B vitamin synthesis by microbiota Microbiota manipulation to block malaria transmission Vector fitness trade-offs under microbiota perturbation The 15 most recent publications reveal a consistent theme of microbial regulation of mosquito physiology, with emphasis on gnotobiotic models , vitamin metabolism , and transmission-blocking strategies . Her work has appeared in Nature Communications , Cell Host & Microbe , and Frontiers in Microbiology . Notable scientific contributions include: Establishing germ-free mosquito protocols for stage-specific studies Identifying biotin toxicity thresholds in Aedes aegypti Mapping microbiota-antibody response interactions She collaborates with teams at Imperial College and EPFL , and her projects are funded by LabEx IBEID and ANR PILGRIM . Dr. Gendrin leads the Reshaping the microbiota of mosquitoes project to model wild microbiota in laboratory settings.

• Entomology
• Insect Vectors
• Host-Pathogen Interactions
• +۱۰ مورد دیگر

N. Alvarez-Rueda serves as an Associate Professor in the Department of Medical Mycology and Parasitology at the University of Nantes' Faculty of Medicine. Her research focuses on host-pathogen interactions in fungal and parasitic infections, particularly Candida albicans persistence mechanisms and Leishmania invasion pathways. Her primary research interests include: Medical Mycology with emphasis on antifungal resistance mechanisms Parasitology focusing on Leishmania pathogenesis Immunological responses to persistent fungal infections One Health approaches to infection control Granuloma formation dynamics in chronic infections Analysis of her publication history (2003-2020) reveals consistent focus on molecular mechanisms of fungal persistence and parasite invasion. Her work demonstrates strong interdisciplinary connections between immunology, microbiology, and pharmacology, with particular emphasis on sterol demethylase mutations in Candida resistance and protein kinase C pathways in Leishmania virulence. Her research has been supported by multiple ANR projects including ANR TEILEISH, ANR AspergillusOne-Health, and ANR OTARI, indicating significant contributions to the field of medical mycology and parasitology.

• Medical Mycology
• Parasitology
• Immunology
• +۴ مورد دیگر

Nidia Alvarez-Rueda is an Associate Professor at the University of Nantes, affiliated with the Department of Parasitology and Medical Mycology within the UFR of Pharmaceutical and Biological Sciences. She holds a dual role as a teacher-researcher at the Institute of Health Research 2 (IICiMed), specializing in infectious diseases and immunity. Her research focuses on understanding fungal persistence mechanisms in Candida infections, particularly investigating the interplay between fungal resistance and host immune responses. Key areas include antifungal resistance dynamics, microbiota interactions influencing infection outcomes, and emerging pathogens like Candida auris. She has pioneered in vitro granuloma models to study host-fungal interactions and contributed to elucidating molecular mechanisms of azole resistance in Candida species. Alvarez-Rueda teaches courses in parasitology, medical mycology, and animal biodiversity at the undergraduate level. Her work is supported by ANR-funded projects exploring 'One Health' approaches to infectious diseases and antimicrobial resistance. She collaborates with multidisciplinary teams at IICiMed targeting therapeutic innovations against persistent infections. Her publications span 2003-2020, consistently addressing fungal pathogenesis and immunity. The experimental models she developed have become foundational tools for studying persistent fungal infections. Despite no specific awards listed, her contributions to medical mycology are recognized through sustained research output and academic service.

• Medical Mycology
• Fungal Resistance
• Immunity and Microbiota
• +۳ مورد دیگر

Pedro Alzari is a leading researcher and Head of the Structural Microbiology Unit within the Department of Structural Biology and Chemistry at the Institut Pasteur in Paris, France. He is a Principal Investigator actively leading research on the structural biology of bacterial pathogens, with a primary focus on Mycobacterium tuberculosis and other Actinobacteria. His work is central to understanding microbial physiology, pathogenesis, and cell signaling mechanisms. His research interests lie at the intersection of structural biology, biochemistry, and microbiology. Dr. Alzari's work focuses on elucidating the three-dimensional structures and functional mechanisms of proteins involved in critical bacterial processes such as cell division, cell wall synthesis, and metabolic regulation. His group employs a wide array of techniques, including X-ray crystallography, cryo-electron microscopy (cryo-EM), and biophysical methods, to study key systems like the PknA/PknB serine/threonine kinases and the divisome-elongasome machinery in Corynebacteriales. A significant theme in his recent work is the discovery of eukaryotic-like signaling and structural systems in bacteria, such as the repurposed gephyrin-like protein in cell division. The trends in Dr. Alzari's recent publications (2023-2025) reveal a strong emphasis on integrative structural biology to solve complex problems in antimicrobial resistance and infectious disease. His work bridges fundamental science with drug discovery, particularly in developing new inhibitors for M. tuberculosis DNA gyrase and Plasmodium proteases. The research consistently involves high-resolution structural analysis (cryo-EM and crystallography) to understand enzyme mechanisms, inhibitor binding, and protein-protein interactions at the atomic level, providing a rational basis for therapeutic intervention. Dr. Alzari has secured significant funding for his research, leading major projects such as the ongoing 'PknA/PknB in mycobacterial cell division' and the completed 'MM4TB' project. He mentors a dynamic team of researchers, including PhD students, postdoctoral fellows, and research engineers, fostering the next generation of scientists in the field. His laboratory is a hub for structural microbiology, contributing to a deeper understanding of bacterial cell biology. The group's work on the divisome and elongasome in Actinobacteria has revealed crucial crosstalk between these machineries, identifying potential new targets for anti-mycobacterial drugs. The team's use of the Institut Pasteur's core facilities, such as the nanoimaging Cryo-EM core facility, underscores their commitment to cutting-edge methodology.

• Structural Biology
• Molecular and Structural Biology
• Microbial Physiology
• +۱۰ مورد دیگر

Pierre Lafaye is the Head of the Antibody Engineering Platform at the Institut Pasteur, a leading institution in biological and medical research. His work is situated within the Technology Department, where he leads a core facility focused on the development and application of VHH (nanobody) technologies. The platform supports a wide range of academic and translational research projects, leveraging the unique properties of nanobodies such as small size, high stability, tissue penetration, and blood-brain barrier crossing ability. Research Interests: Dr. Lafaye’s research spans multiple domains, including cancer immunotherapy (e.g., targeting ILT4 as an immune checkpoint), neurodegenerative diseases (e.g., imaging Alzheimer’s plaques and tangles), infectious diseases (e.g., SARS-CoV-2 diagnostics and therapeutics), and antimicrobial resistance (e.g., targeting β-lactamases). His expertise lies in phage display, protein engineering, and in vivo molecular imaging. He has pioneered the use of dimeric VHHs for sensitive immunoassays and targeted diagnostics. Recent Publication Trends: His recent publications (2021–2024) reflect a strong emphasis on structural biology (using cryo-EM), viral entry mechanisms (especially coronaviruses), and the therapeutic and diagnostic application of nanobodies. Collaborative, high-impact studies in journals like Nature , Cell , and Nature Communications highlight his role in cutting-edge interdisciplinary research. Scientific Awards: While no specific awards are listed in the provided text, his leadership in IBiSA-certified core facilities and participation in major networks like EuroMabNet, Core For Life (CFL), and CTLS reflect recognition of his technical and scientific contributions. Advising and Grants: Dr. Lafaye has supervised multiple PhD students and postdoctoral researchers, indicating an active mentoring role. He leads several funded projects, including the ongoing CORONABODIES and Advances in Cancer Immunotherapy projects, as well as completed initiatives like ChagasDiag and VenoMATIcs. These projects involve collaborations across international Pasteur Institutes and academic partners. Labs and Teams: As head of the Antibody Engineering Platform, he oversees a multidisciplinary team comprising research engineers, technicians, postdocs, and PhD students. The facility is part of broader transversal initiatives at the Institut Pasteur, including those in brain connectivity, cancer, and emerging infectious diseases.

• Antibody Engineering
• Nanobodies (VHH)
• Immunotherapy
• +۱۳ مورد دیگر

Didier Ménard is a Full Professor at the University of Strasbourg and Director of the Institute of Parasitology and Tropical Diseases (UR7292). Since 2023, he serves as a visiting researcher in the Malaria Parasite Biology and Vaccines Unit at the Pasteur Institute, headed by Chetan Chitnis. Previously, from 2017 to 2021, he led the Malaria Genetics and Resistance Group and later the Malaria Genetics and Resistance Unit at the Pasteur Institute Paris. Dr. Ménard's research focuses on antimalarial drug resistance in both Plasmodium falciparum and Plasmodium vivax parasites. His work spans molecular epidemiology, genetics of resistance mechanisms, and development of surveillance tools for drug-resistant malaria. He has conducted extensive field research in Africa (Central African Republic, Madagascar) and Southeast Asia (Cambodia), contributing significantly to our understanding of malaria transmission dynamics and resistance patterns. His research has revealed critical insights into P. vivax infection mechanisms in Duffy-negative populations and identified key molecular markers of artemisinin and piperaquine resistance in P. falciparum . Most notably, his team demonstrated that mutations in the K13 propeller domain and amplifications of plasmepsin II and III genes are major determinants of artemisinin and piperaquine resistance, respectively. Analysis of his recent publications (2023-2025) reveals a strong focus on emerging drug resistance patterns, particularly artemisinin-resistant malaria in Africa, molecular mechanisms of parasite invasion, and genomic epidemiology of P. vivax in sub-Saharan Africa. His work increasingly addresses the dual challenges of diagnostic limitations (HRP2-negative malaria) and treatment failures in malaria-endemic regions. Dr. Ménard has led several significant research projects including IMPRIMA (Implementing Primaquine Single Low Dose in Africa), TipTop (monitoring sulfadoxine-pyrimethamine resistance), development of new biomarkers for malaria detection, and SaMARA (Surveillance and Monitoring of Antimalarial Resistance in Africa). His laboratory utilizes advanced genomic and molecular techniques to characterize drug-resistant parasite populations.

• Malaria
• Antimalarial drug resistance
• Plasmodium falciparum
• +۵ مورد دیگر

Odile Sismeiro is a Senior Research Engineer at the Transcriptome and Epigenome Platform within the Biomics Pole at the Institut Pasteur . With over three decades of experience, she has been pivotal in advancing RNA sequencing technologies since 2009. Diplôme Universitaire de Technologie Diplôme d’Études Scientifiques et Techniques from CNAM, Paris Her research intertwines Transcriptomics , Microbial Genetics , and Host-Pathogen Interactions , particularly through developing and applying: DNA array technology Next-Generation Sequencing (NGS) RNA-seq data analysis pipelines Key publication themes highlight: Streptococcus pathogenicity networks RNA-based immune sensing mechanisms Vector-borne disease genetics Microbial biofilm regulation She actively contributes to: Scientific training programs Technological development projects Collaborative research across multiple Institut Pasteur units

• Transcriptomics
• Next-Generation Sequencing (NGS)
• Microbial Genetics
• +۳ مورد دیگر